Clinical Trial: Study of KITE-197 in Participants With Relapsed or Refractory Large B-cell Lymphoma
Study Status: Completed
Recruit Status: RECRUITING
Condition: Relapsed/Refractory Large B-cell Lymphoma
Study Type: INTERVENTIONAL
Official Title: A Phase 1 Open-label, Single Arm, Multicenter Study Evaluating the Safety and Efficacy of KITE-197 in Subjects With Relapsed or Refractory Large B-cell Lymphoma
Brief Summary:
This study will have two Phases: Phase 1a and Phase 1b.The goal of Phase 1a of this clinical study is to learn more about the safety, tolerability and dosing of study drug KITE-197, in participants with relapsed or refractory large B-cell lymphoma (r/rLBCL).The goal of Phase 1b of this clinical study is learn about the effectiveness of the recommended dose of KITE-197 in participants with r/r LBCL.The primary objectives of this study are:Phase 1a: To evaluate the safety of KITE-197 in participants with…
Read more